PATRICK J. HANNA, Magistrate Judge.
This Court, having reviewed Plaintiff's Unopposed Motion to Approve Settlement as to Claims of Sharon M. Asp-Maytash, as Successor and Derivative Claimant; and Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. (collectively "Takeda"), the parties having received due notice of and having had the opportunity to be heard, and this Court having considered all submissions made, I recommend to the Court that the Motion be
GRANTED and
The settlement by and between Plaintiff, Sharon M. Asp-Maytash, as Successor and Derivative Claimant; individually and as legal heir to the Estate of Svend Asp, deceased, and Takeda, as notice to the Court on June 30, 2017 be
APPROVED.
The Court has jurisdiction of this matter by virtue of the Plaintiffs participating in the Actos MDL Master Settlement Agreement.
ANY PARTY OBJECTING TO THIS RECOMMENDATION SHALL SUBMIT OBJECTIONS, IN WRITING, DIRECTLY TO JUDGE DOHERTY'S CHAMBERS — AND SHALL NOT FILE THE OBJECTION INTO THE RECORD — NO LATER THAN TEN (10) DAYS AFTER ENTRY OF THIS RECOMMENDATION.
If there is no objection within ten (10) days of the entry of this Recommendation, the Recommendation will become an Order.